Antientity tumour medicinal composition containing topoenzyme inhibitor
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- DASEN BIOLOGICAL PHARMA CO LTD
- Publication Date
- 2005-10-26
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
(1) Technical field
[0001] The invention relates to an anti-solid tumor pharmaceutical composition containing a topozyme inhibitor, which belongs to the technical field of medicines. (2) Background technology
[0002] Cancer treatment mainly includes surgery, radiotherapy and chemotherapy. Among the various chemotherapeutic drugs used, topoase inhibitors are more effective and have been widely used in various malignant tumors. Since topoase inhibitors exert their anti-tumor effect by inhibiting RNA synthesis, and the DNA repair function in many tumor cells is significantly increased after treatment, so effectively reducing or inhibiting the DNA repair function in tumor cells has become the current research topic. focus.
[0003] It has recently been found that inactivating or inhibiting intracellular DNA repair proteins can enhance the sensitivity of some tumor cells to chemotherapy, see Dolan et al. ""Cancer Research" 51 pp. 3367-3372 (1991) (Dolan et al., Cancer Res., 5...